Group One Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-59,500
| Closed | -$10.2M | – | 9193 |
|
|
2021
Q3 | $10.2M | Buy |
59,500
+59,400
| +59,400% | +$7.77M | 0.01% | 1047 |
|
|
2021
Q2 | $13K | Sell |
100
-7,300
| -99% | -$921K | ﹤0.01% | 7425 |
|
|
2021
Q1 | $1M | Buy |
7,400
+7,200
| +3,600% | +$930K | ﹤0.01% | 3224 |
|
|
2020
Q4 | $26K | Sell |
200
-2,200
| -92% | -$258K | ﹤0.01% | 5388 |
|
|
2020
Q3 | $270K | Sell |
2,400
-1,600
| -40% | -$159K | ﹤0.01% | 3408 |
|
|
2020
Q2 | $381K | Buy |
4,000
+2,000
| +100% | +$193K | ﹤0.01% | 2855 |
|
|
2020
Q1 | $180K | Buy |
2,000
+500
| +33% | +$38.9K | ﹤0.01% | 2842 |
|
|
2019
Q4 | $80K | Buy |
+1,500
| New | +$68.4K | ﹤0.01% | 3777 |
|
|
2019
Q3 | – | Sell |
-2,000
| Closed | -$82K | – | 5753 |
|
|
2019
Q2 | $82K | Hold |
2,000
| – | – | ﹤0.01% | 3498 |
|
|
2019
Q1 | $93K | Sell |
2,000
-1,300
| -39% | -$57.1K | ﹤0.01% | 3228 |
|
|
2018
Q4 | $144K | Sell |
3,300
-5,500
| -63% | -$275K | ﹤0.01% | 2929 |
|
|
2018
Q3 | $504K | Sell |
8,800
-10,200
| -54% | -$501K | ﹤0.01% | 2272 |
|
|
2018
Q2 | $922K | Buy |
+19,000
| New | +$692K | 0.01% | 1797 |
|
|
2018
Q1 | – | Sell |
-2,100
| Closed | -$89K | – | 5501 |
|
|
2017
Q4 | $89K | Sell |
2,100
-10,000
| -83% | -$375K | ﹤0.01% | 3418 |
|
|
2017
Q3 | $452K | Buy |
12,100
+1,100
| +10% | +$38.2K | ﹤0.01% | 2160 |
|
|
2017
Q2 | $334K | Buy |
+11,000
| New | +$319K | ﹤0.01% | 2262 |
|
|
2016
Q3 | – | Sell |
-700
| Closed | -$24K | – | 5056 |
|
|
2016
Q2 | $24K | Sell |
700
-1,000
| -59% | -$32.5K | ﹤0.01% | 3712 |
|
|
2016
Q1 | $45K | Sell |
1,700
-8,300
| -83% | -$241K | ﹤0.01% | 3317 |
|
|
2015
Q4 | $488K | Buy |
+10,000
| New | +$360K | 0.01% | 1836 |
|
|
2015
Q3 | – | Sell |
-100
| Closed | -$3K | – | 5346 |
|
|
2015
Q2 | $3K | Sell |
100
-16,600
| -99% | -$536K | ﹤0.01% | 4633 |
|
|
2015
Q1 | $636K | Buy |
16,700
+9,500
| +132% | +$378K | 0.01% | 1425 |
|
|
2014
Q4 | $281K | Buy |
7,200
+900
| +14% | +$31.4K | ﹤0.01% | 2024 |
|
|
2014
Q3 | $191K | Buy |
6,300
+5,600
| +800% | +$158K | ﹤0.01% | 2405 |
|
|
2014
Q2 | $24K | Buy |
+700
| New | +$23.4K | ﹤0.01% | 4051 |
|
Group One Trading's XLRN Position: Q4 2021 in Review
Group One Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 21,002 shares — an estimated $3.61M sold.
Group One Trading first reported a position in XLRN in Q3 2014 and held it in 9 quarters. The position peaked at $3.61M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Group One Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 21,002 Acceleron Pharma shares in Q4 2021, an estimated $3.61M.
- Group One Trading first reported a position in Acceleron Pharma in Q3 2014 and held it in 9 quarters.
- Group One Trading's Acceleron Pharma position peaked at $3.61M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.